Floatz logo

5-azacytidine

Estrogen Receptor and/or Progesterone Receptor Positive

City of Hope Medical CenterPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Estrogen Receptor and/or Progesterone Receptor Positive cohort.

Asset / SponsorPhaseRating
Calcium
University of Illinois at Chicago
Phase 2BB
VITAMIN D
University of Illinois at Chicago
Phase 2BB
VENLOR
University of Illinois at Chicago
Phase 2BB

Same molecule, other indications

5-azacytidine is also rated in:

Recurrent Non-Hodgkin LymphomaDormant
BB
Indicative ·
70 / 100
View asset →
Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic LeukemiaDormant
BB
Indicative ·
65 / 100
View asset →
myelodysplastic syndromeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →